Alkermes Financial Ratios
NASDAQ: ALKSHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alkermes ratio analysis
Alkermes earned a net margin of 16.4% in FY 2025, down from 23.6% a year earlier. Gross margin was 86.7% compared with a median of 83.2% over the prior 9 years. Return on equity reached 13.3%, meaning Alkermes generated 0.13 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.00, and the current ratio was 3.55. At the end of FY 2025, ALKS traded at 19.8 times earnings; across the 3 fiscal years shown, its year-end P/E ranged from 13.2 to 19.8, with a median of 13.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Alkermes financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 19.76 | 13.38 | 13.21 | — | — | — | — | — | — | — |
| Price / sales | 3.15 | 3.08 | 2.77 | 3.85 | 3.19 | 3.05 | 2.58 | 4.25 | 9.29 | 11.29 |
| Price / book | 2.56 | 3.28 | 3.83 | 4.10 | 3.36 | 2.97 | 2.79 | 3.97 | 6.98 | 6.96 |
| Gross margin | 86.7% | 84.2% | 84.8% | 80.4% | 83.2% | 82.8% | 84.6% | 83.9% | 82.9% | 82.3% |
| Operating margin | 17.2% | 27.0% | 24.9% | -0.5% | 8.3% | -10.8% | -15.0% | -9.1% | -16.4% | -28.0% |
| Net margin | 16.4% | 23.6% | 21.4% | -14.2% | -4.1% | -10.7% | -16.8% | -12.7% | -17.5% | -28.0% |
| Free cash flow margin | 32.5% | 26.0% | 21.2% | -1.5% | 6.3% | 3.9% | -1.6% | 2.7% | -3.6% | -14.4% |
| Return on equity (ROE) | 13.3% | 25.1% | 29.6% | -15.2% | -4.3% | -10.4% | -18.1% | -11.9% | -13.1% | -17.2% |
| Return on assets (ROA) | 9.7% | 17.9% | 16.7% | -8.1% | -2.4% | -5.7% | -10.9% | -7.6% | -8.8% | -12.1% |
| Debt / equity | 0.00 | — | 0.24 | 0.28 | 0.27 | 0.26 | 0.26 | 0.24 | 0.23 | 0.23 |
| Current ratio | 3.55 | 3.04 | 2.86 | 2.27 | 2.25 | 2.53 | 2.46 | 2.89 | 2.78 | 3.73 |
| Revenue growth | -5.2% | -6.4% | 49.6% | -5.3% | 13.0% | -11.3% | 7.0% | 21.1% | 21.1% | 18.7% |
| EPS growth | -34.1% | 3.3% | — | — | — | — | — | — | — | — |